Viewing Study NCT00383903


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2025-12-25 @ 4:44 PM
Study NCT ID: NCT00383903
Status: COMPLETED
Last Update Posted: 2016-09-15
First Post: 2006-10-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module